Central Venous Catheter Market Size, Share, Trends and Forecast 2022-2032

 The global central venous catheter market is expected to develop at a 5.1% CAGR between 2022 and 2032. The global market reached US$ 2.9 billion in 2021 and is predicted to reach US$ 3.1 billion by the end of 2022. Because of the increased prevalence of cardiovascular diseases and malignancies, the worldwide demand for central venous catheters is expected to rise to US$ 5.1 billion by 2032.

As compared to the historical analysis of the global central venous catheter market, the CAGR registered was about 4.9% from 2012 to 2021. The present forecast period registered a growth of 5.1% from 2022 to 2032. The rising usage of central venous catheters across healthcare facilities for giving fluids, blood, or medications to critically ill patients is a key factor driving growth in the global central venous catheter market.

Central venous catheters are delicately placed in veins in the neck, groin, chest, or through veins in the arms in order to ease the delivery of fluids and therapies. This device is useful for patients who are unable to eat food or medicine through their mouths. Therefore, the rising prevalence of cardiovascular disease and chronic kidney disease, along with the growing need for prolonged intravenous therapies in critically ill patients, will continue to boost the demand for venous catheters during the forecast period.

To learn more about this report: https://www.futuremarketinsights.com/reports/central-venous-catheter-market

Key Takeaways

·         There is a surge in the demand for various types of central venous catheter products due to which key manufacturers are investing in focusing on research and development to introduce better and more efficient products. Owing to these factors are likely to boost the growth throughout the forecast period.

·         Widespread technological advancements and the adoption of high-tech equipment in medical procedures and medical device insertions are bringing the central venous catheter market into the limelight. Increased usage of ultrasound-guided insertions has proved to improve the safety and effectiveness of CVC placement and helped in reducing the complications associated with the procedure.

·         More accessibility to product-based solutions, such as quality control and infection prevention guidelines has further fueled growth in the market resulting in a hike in the overall revenue growth of the global central venous catheter market.

·         The growth in the central venous catheter market is driven by the global burden of diseases, increasing expendable income, and the rising awareness of the adoption of surgical procedures for managing illnesses.

·         On the basis of product category, the non-tunneled catheter sub-segment accounts for about 77.0% of the total market share and is likely to retain its dominance during the forecast period. In order to efficiently care for critically ill patients, central venous catheter insertion is a routine and frequently required procedure.

Comments

Post a Comment

Popular posts from this blog

Orthopedic Trauma Devices Market is projected to reach a valuation of US$ 21.2 Bn by 2033 | FMI

Image
  The net worth of the Orthopaedic Trauma Devices Market is expected to increase from US$ 10.7 billion in 2023 to more than US$ 21.2 billion by 2033. From 2023 to 2033, the orthopaedic trauma device market is expected to grow at a 7.1% CAGR . To learn more about this report @ https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Orthopedic Trauma Devices market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Orthopedic Trauma Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcar
Read more

Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031

Image
Diabetes is becoming more common as poor lifestyle choices continue to be prominent around the world. Insulin pens are a widely used method of treating diabetic individuals. Given this, Future Market Insights predicts that insulin pen sales will reach US$ 30,407 million in 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster. Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential. Type 2 diabetes cases are common, but it can be prevented or de
Read more

Molecular Biology Enzymes, Kits & Reagents Market Size, Share, Growth, Forecast through 2032

Image
  According to a recent Future Market Insights report, the global Molecular Biology Enzymes, Kits & Reagents Market will grow dramatically between 2022 and 2032. By 2032, global sales of molecular biology enzymes, kits, and reagents are expected to total approximately US$ 48,476.41 million. Technological Advancements Leading to Enhanced Efficiency & Greater Precision of Molecular Biology Enzymes, Kits & Reagents The manufacturers of molecular biology enzymes, kits, and reagents have contributed significantly to technical breakthroughs by focusing on creating cutting-edge goods in an effort to diversify their product offerings. The cutting-edge items support the study procedures by providing features like increased precision and efficiency. One of the best instances of this is Thermo Fisher Scientific, Inc.’s SMART Digest Kit, which was created specifically for biopharmaceutical and proteomic applications. This kit reduces the time required for sample preparation while
Read more